Alzheimer’s disease (AD) is characterized by the accumulation of amyloid β and phosphorylated τ protein aggregates in the brain, which leads to the loss of neurons. Under the microscope, the function of mitochondria is uniquely primed to play a pivotal role in neuronal cell survival, energy metabolism, and cell death. Research studies indicate that mitochondrial dysfunction, excessive oxidative damage, and defective mitophagy in neurons are early indicators of AD. This review article summarizes the latest development of mitochondria in AD: 1) disease mechanism pathways, 2) the importance of mitochondria in neuronal functions, 3) metabolic pathways and functions, 4) the link between mitochondrial dysfunction and mitophagy mechanisms in AD, and 5) the development of potential mitochondrial-targeted therapeutics and interventions to treat patients with AD.
2021 Alzheimer’s disease facts and figures. 2021. Alzheimers Dement17(3):327–406. doi:10.1002/alz.12328
2.
2022 Alzheimer’s disease facts and figures. 2022. Alzheimers Dement18(4):700–89. doi:10.1002/alz.12638
3.
AbrischRGGumbinSCWisniewskiBTLacknerLLVoeltzGK. 2020. Fission and fusion machineries converge at ER contact sites to regulate mitochondrial morphology. J Cell Biol219(4):e201911122. doi:10.1083/jcb.201911122
4.
AhmadTAggarwalKPattnaikBMukherjeeSSethiTTiwariBK, and others. 2013. Computational classification of mitochondrial shapes reflects stress and redox state. Cell Death Dis4(1):e461. doi:10.1038/cddis.2012.213
5.
AlbertsBJohnsonALewisJRaffMRobertsKWalterP.2002. The transport of proteins into mitochondria and chloroplasts. In: Molecular biology of the cell. 4th ed.New York (NY): Garland Science. https://www.ncbi.nlm.nih.gov/books/NBK26828/
6.
BackesSHerrmannJM. 2017. Protein translocation into the intermembrane mpace and matrix of mitochondria: mechanisms and driving Forces. Front Mol Biosci4:83. doi:10.3389/fmolb.2017.00083
7.
BagurRHajnóczkyG.2017. Intracellular Ca2+ sensing: its role in calcium homeostasis and signaling. Mol Cell66(6):780–8. doi:10.1016/j.molcel.2017.05.028
8.
BayrhuberMMeinsTHabeckMBeckerSGillerKVillingerS, and others. 2008. Structure of the human voltage-dependent anion channel. Proc Natl Acad Sci U S A105(40):15370–5. doi:10.1073/pnas.0808115105
BoucardAMarinFMonternierPABrandMle GrandB.2019. P4607A specific complex I-induced ROS modulator, OP2113, is a new cardioproctective agent against acute myocardial infarction injuries during reperfusion. Euro Heart J40Suppl 1. doi:10.1093/eurheartj/ehz745.0990
11.
BrandMDOrrALPerevoshchikovaIVQuinlanCL. 2013. The role of mitochondrial function and cellular bioenergetics in ageing and disease. Br J Dermatol169Suppl 2(2):1–8. doi:10.1111/bjd.12208
12.
CaiQJeongYY. 2020. Mitophagy in Alzheimer’s disease and other age-related neurodegenerative diseases. Cells9(1):150. doi:10.3390/cells9010150
13.
CaiQTammineniP.2017. Mitochondrial aspects of synaptic dysfunction in Alzheimer’s disease. J Alzheimers Dis57(4):1087–103. doi:10.3233/JAD-160726
14.
CaiQZakariaHMShengZH. 2012a. Long time-lapse imaging reveals unique features of PARK2/PARKIN-mediated mitophagy in mature cortical neurons. Autophagy8(6):976–8. doi:10.4161/auto.20218.
15.
CaiQZakariaHMSimoneAShengZH. 2012b. Spatial PARKIN translocation and degradation of damaged mitochondria via mitophagy in live cortical neurons. Curr Biol22(6):545–52. doi:10.1016/j.cub.2012.02.005
16.
CallensMKraskovskayaNDerevtsovaKAnnaertWBultynckGBezprozvannyI, and others. 2021. The role of Bcl-2 proteins in modulating neuronal Ca2+ signaling in health and in Alzheimer’s disease. Biochim Biophys Acta Mol Cell Res1868(6):118997. doi:10.1016/j.bbamcr.2021.118997
17.
CaoYKlionskyDJ. 2007. Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res17(10):839–49. doi:10.1038/cr.2007.78
18.
ChanDC. 2012. Fusion and fission: interlinked processes critical for mitochondrial health. Annu Rev Genet46:265–87. doi:10.1146/annurev-genet-110410-132529
19.
CharmpilasNFangEFPalikarasK.2022. Mitophagy and neuroinflammation: a compelling interplay. Curr Neuropharmacol28. doi:10.2174/1570159X20666220628153632
20.
ChenHChanDC.2010. Physiological functions of mitochondrial fusion. Ann N Y Acad Sci1201:21–5. doi:10.1111/j.1749-6632.2010.05615.x
21.
ChenHMcCafferyJMChanDC. 2007. Mitochondrial fusion protects against neurodegeneration in the cerebellum. Cell130(3):548–62. doi:10.1016/j.cell.2007.06.026
22.
ChoiGELeeHJChaeCWChoJHJungYHKimJS, and others. 2021. BNIP3L/NIX-mediated mitophagy protects against glucocorticoid-induced synapse defects. Nat Commun12(1):487. doi:10.1038/s41467-020-20679-y
23.
CipolatSMartinsdeBritoODal ZilioBScorranoL.2004. OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc Natl Acad Sci U S A101(45):15927–32. doi:10.1073/pnas.0407043101
24.
DeasEWoodNWPlun-FavreauH.2011. Mitophagy and Parkinson’s disease: the PINK1–parkin link. Biochim Biophys Acta1813(4):623–33. doi:10.1016/j.bbamcr.2010.08.007
25.
d’ErricoPMeyer-LuehmannM.2020. Mechanisms of pathogenic tau and Aβ protein spreading in Alzheimer’s disease. Front Aging Neurosci12:265. doi:10.3389/fnagi.2020.00265
26.
DeshwalSFiedlerKULangerT.2020. Mitochondrial proteases: multifaceted regulators of mitochondrial plasticity. Annu Rev Biochem89:501–528. doi:10.1146/annurev-biochem-062917-012739
27.
De StrooperBIwatsuboTWolfeMS. 2012. Presenilins and γ-secretase: structure, function, and role in Alzheimer’s disease. Cold Spring Harb Perspect Med2(1). doi:10.1101/cshperspect.a006304
28.
DetailleDPasdoisPSémontAdos SantosPDiolezP.2019. An old medicine as a new drug to prevent mitochondrial complex I from producing oxygen radicals. PLoS One14(5):e0216385. doi:10.1371/journal.pone.0216385
29.
DeTureMADicksonDW. 2019. The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener14(1):32. doi:10.1186/s13024-019-0333-5
30.
D’SilvaPDSchilkeBWalterWAndrewACraigEA. 2003. J protein cochaperone of the mitochondrial inner membrane required for protein import into the mitochondrial matrix. Proc Natl Acad Sci U S A100(24):13839–44. doi:10.1073/pnas.1936150100
31.
DuchenMR. 2000. Mitochondria and calcium: from cell signalling to cell death. J Physiol529Pt 1:57–68. doi:10.1111/j.1469-7793.2000.00057.x
32.
EganEDCollinsK.2012. Biogenesis of telomerase ribonucleoproteins. RNA18(10):1747–59. doi:10.1261/rna.034629.112
33.
FangEFHouYPalikarasKAdriaanseBAKerrJSYangB, and others. 2019. Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease. Nat Neurosci22(3):401–12. doi:10.1038/s41593-018-0332-9
34.
FerreeAShirihaiO.2012. Mitochondrial dynamics: the intersection of form and function. Adv Exp Med Biol748:13–40. doi:10.1007/978-1-4614-3573-0_2
35.
FuZJWangZYXuLChenXHLiXXLiaoWT, and others. 2020. HIF-1α-BNIP3–mediated mitophagy in tubular cells protects against renal ischemia/reperfusion injury. Redox Biol36:101671. doi:10.1016/j.redox.2020.101671
36.
GeYShiXBoopathySMcDonaldJSmithAWChaoLH. 2020. Two forms of opa1 cooperate to complete fusion of the mitochondrial inner-membrane. Elife9:e50973. doi:10.7554/eLife.50973
37.
GeislerSHolmströmKMSkujatDFieselFCRothfussOCKahlePJ, and others. 2010. PINK1/PARKIN-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol12(2):119–31. doi:10.1038/ncb2012
38.
GellerichFNWagnerMKapischkeMWickerUBrdiczkaD.1993. Effect of macromolecules on the regulation of the mitochondrial outer membrane pore and the activity of adenylate kinase in the inter-membrane space. Biochim Biophys Acta1142(3):217–27. doi:10.1016/0005-2728(93)90150-E
39.
GhavamiSShojaeiSYeganehBAndeSRJangamreddyJRMehrpourM, and others. 2014. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol112:24–49. doi:10.1016/j.pneurobio.2013.10.004
40.
GiorgioVPetronilliVGhelliACarelliVRugoloMLenazG, and others. 2012. The effects of idebenone on mitochondrial bioenergetics. Biochim Biophys Acta1817(2):363–9. doi:10.1016/j.bbabio.2011.10.012
41.
GiraudMFPaumardPSoubannierVVaillierJArselinGSalinB, and others. 2002. Is there a relationship between the supramolecular organization of the mitochondrial ATP synthase and the formation of cristae?Biochim Biophys Acta. 1555(1–3):174–80.
42.
GlancyBBalabanRS. 2012. Role of mitochondrial Ca2+ in the regulation of cellular energetics. Biochemistry51(14):2959–73. doi:10.1021/bi2018909
43.
HanSJeongYYSheshadriPSuXCaiQ.2020. Mitophagy regulates integrity of mitochondria at synapses and is critical for synaptic maintenance. EMBO Rep21(9):e49801. doi:10.15252/embr.201949801
44.
HanSZhangMJeongYYMargolisDJCaiQ.2021. The role of mitophagy in the regulation of mitochondrial energetic status in neurons. Autophagy17(12):4182–201. doi:10.1080/15548627.2021.1907167
45.
HawkesCASullivanPMHandsSWellerRONicollJACarareRO. 2012. Disruption of arterial perivascular drainage of amyloid-β from the brains of mice expressing the human APOE ε4 allele. PLoS One7(7). doi:10.1371/journal.pone.0041636
46.
HayMBarnesCHuentelmanMBrintonRRyanL.2020. Hypertension and age-related cognitive impairment: common risk factors and a role for precision aging. Curr Hypertens Rep22(10):80. doi:10.1007/s11906-020-01090-w
47.
HeFRuXWenT.2020. NRF2, a transcription factor for stress response and beyond. Int J Mol Sci21(13):4777. doi:10.3390/ijms21134777 doi:10.3390/biom12030427
48.
JaberSPolsterBM. 2014. Idebenone and neuroprotection: antioxidant, pro-oxidant, or electron carrier?J Bioenerg Biomembr47(1–2):111–18. doi:10.1007/s10863-014-9571-y
49.
JanikiewiczJSzymańskiJMalinskaDPatalas-KrawczykPMichalskaBDuszyńskiJ, and others. 2018. Mitochondria-associated membranes in aging and senescence: structure, function, and dynamics. Cell Death Dis9(3):332. doi:10.1038/s41419-017-0105-5
50.
JeongYYHanSJiaNZhangMSheshadriPTammineniP, and others. 2022. Broad activation of the Parkin pathway induces synaptic mitochondrial deficits in early tauopathy. Brain145(1):305–23. doi:10.1093/brain/awab243
51.
JohnAReddyPH. 2021. Synaptic basis of Alzheimer’s disease: focus on synaptic amyloid beta, P-tau and mitochondria. Ageing Res Rev65:101208. doi:10.1016/j.arr.2020.101208
52.
JohriAChandraA.2021. MAM: errors in ER-mitochondria connections in neurodegenerative diseases. Brain Sci11(11):1437. doi:10.3390/brainsci11111437
53.
KambohMDemirciFWangXMinsterRLCarrasquilloMMPankratzVS, and others. 2012. Genome-wide association study of Alzheimer’s disease. Transl Psychiatry2. doi:10.1038/tp.2012.45
54.
KarbowskiMNeutznerA.2012. Neurodegeneration as a consequence of failed mitochondrial maintenance. Acta Neuropathol123(2):157–71. doi:10.1007/s00401-011-0921-0
KoukourakisMIKalamidaDGiatromanolakiAZoisCESivridisEPouliliouS, and others. 2015. Autophagosome proteins LC3A, LC3B and LC3C have distinct subcellular distribution kinetics and expression in cancer cell lines. PLoS One10(9):e0137675. doi:10.1371/journal.pone.0137675
57.
KowaldAKirkwoodTB. 2011. Evolution of the mitochondrial fusion-fission cycle and its role in aging. Proc Natl Acad Sci U S A108(25):10237–42. doi:10.1073/pnas.1101604108
58.
KshirsagarSSawantNMortonHReddyAPReddyPH. 2022. Protective effects of mitophagy enhancers against amyloid beta-induced mitochondrial and synaptic toxicities in Alzheimer’s disease. Hum Mol Genet31(3):423–39. doi:10.1093/hmg/ddab262
59.
KühlbrandtW. 2015. Structure and function of mitochondrial membrane protein complexes. BMC Biol13:89. doi:10.1186/s12915-015-0201-x
60.
KumaAMatsuiMMizushimaN.2007. LC3, an autophagosome marker, can be incorporated into protein aggregates independent of autophagy: caution in the interpretation of LC3 localization. Autophagy3(4):323–8. doi:10.4161/auto.4012
61.
LanoiseléeHMNicolasGWallonDRovelet-LecruxALacourMRousseauS, and others. 2017. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: a genetic screening study of familial and sporadic cases. PLoS Med14(3). doi:10.1371/journal.pmed.1002270
62.
LeeSMinKT. 2018. The interface between ER and mitochondria: molecular compositions and functions. Mol Cells41(12):1000–7. doi:10.14348/molcells.2018.0438
63.
LiYZhengWLuYZhengYPanLWuX, and others. 2021. BNIP3L/NIX-mediated mitophagy: molecular mechanisms and implications for human disease. Cell Death Dis13(1):14. doi:10.1038/s41419-021-04469-y
64.
LiZShueFZhaoNShinoharaMBuG.2020. APOE2: protective mechanism and therapeutic implications for Alzheimer’s disease. Mol Neurodegener5(1). doi:10.1186/s13024-020-00413-4
65.
LiuCCLiuCCKanekiyoTXuHBuG.2013. Apolipoprotein E and Alzheimer’s disease: risk, mechanisms and therapy. Nat Rev Neurol9(2). doi:10.1038/nrneurol.2012.263
66.
LiuYZhuX.2017. Endoplasmic reticulum-mitochondria tethering in neurodegenerative diseases. Transl Neurodegener6:21. doi:10.1186/s40035-017-0092-6
67.
LosónOCSongZChenHChanDC. 2013. Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission. Mol Biol Cell24(5):659–67. doi:10.1091/mbc.e12-10-0721
68.
MaKChenGLiWKeppOZhuYChenQ.2020. Mitophagy, mitochondrial homeostasis, and cell fate. Front Cell Dev Biol8:467. doi:10.3389/fcell.2020.00467
69.
MaQ.2013. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol53:401–26. doi:10.1146/annurev-pharmtox-011112-140320
70.
ManczakMKandimallaRYinXReddyPH. 2019. Mitochondrial division inhibitor 1 reduces dynamin-related protein 1 and mitochondrial fission activity. Hum Mol Genet28(2):177–99. doi:10.1093/hmg/ddy335
71.
ManczakMReddyPH. 2012. Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer’s disease. Hum Mol Genet21(23):5131–46. doi:10.1093/hmg/dds360
72.
ManczakMSheikoTCraigenWJReddyPH. 2013. Reduced VDAC1 protects against Alzheimer’s disease, mitochondria, and synaptic deficiencies. J Alzheimers Dis37(4):679–90. doi:10.3233/JAD-130761
73.
MannellaCA. 2020. Consequences of folding the mitochondrial inner membrane. Front Physiol11:536. doi:10.3389/fphys.2020.00536
74.
MarinkovićMŠprungMNovakI.2021. Dimerization of mitophagy receptor BNIP3L/NIX is essential for recruitment of autophagic machinery. Autophagy17(5):1232–43. doi:10.1080/15548627.2020.1755120
75.
Martínez-ReyesIChandelNS. 2020. Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun11(1):102. doi:10.1038/s41467-019-13668-3
76.
MattsonMPGleichmannMChengA.2008. Mitochondria in neuroplasticity and neurological disorders. Neuron60(5):748–66. doi:10.1016/j.neuron.2008.10.010.
77.
Matuz-MaresDGonzález-AndradeMAraiza-VillanuevaMGVilchis-LanderosMMVázquez-MezaH.2022. Mitochondrial calcium: effects of its imbalance in disease. Antioxidants (Basel)11(5):801. doi:10.3390/antiox11050801
MiaoJShiRLiLChenFZhouYTungYC, and others. 2019. Pathological tau from Alzheimer’s brain induces site-specific hyperphosphorylation and SDS- and reducing agent-resistant aggregation of tau in vivo. Front Aging Neurosci11:34. doi:10.3389/fnagi.2019.00034
80.
MichaelsonDM. 2014. APOE ε4: the most prevalent yet understudied risk factor for Alzheimer’s disease. Alzheimers Dement10(6). doi:10.1016/j.jalz.2014.06.015
81.
MishraPChanDC. 2014. Mitochondrial dynamics and inheritance during cell division, development and disease. Nat Rev Mol Cell Biol15(10):634–46. doi:10.1038/nrm3877
82.
MortonHKshirsagarSOrlovEBunquinLESawantNBolengL, and others. 2021. Defective mitophagy and synaptic degeneration in Alzheimer’s disease: focus on aging, mitochondria and synapse. Free Radic Biol Med172:652–67. doi:10.1016/j.freeradbiomed.2021.07.013
83.
NakamuraYKitamuraNShinogiDYoshidaMGodaOMuraiR, and others. 2012. BNIP3 and NIX mediate mieap-induced accumulation of lysosomal proteins within mitochondria. PLoS One7(1):e30767. doi:10.1371/journal.pone.0030767
84.
NarendraDPYouleRJ. 2011. Targeting mitochondrial dysfunction: role for PINK1 and PARKIN in mitochondrial quality control. Antioxid Redox Signal14(10):1929–38. doi:10.1089/ars.2010.3799
85.
NemaniNCarvalhoETomarDDongZKetschekABrevesSL, and others. 2018. MIRO-1 determines mitochondrial shape transition upon GPCR activation and Ca2+ stress. Cell Rep23(4):1005–19. doi:10.1016/j.celrep.2018.03.098
86.
NgoHBLovelyGAPhillipsRChanDC. 2014. Distinct structural features of TFAM drive mitochondrial DNA packaging versus transcriptional activation. Nat Commun5:3077. doi:10.1038/ncomms4077
87.
NowinskiSMSolmonsonARusinSFMaschekJABensardCLFogartyS, and others. 2020. Mitochondrial fatty acid synthesis coordinates oxidative metabolism in mammalian mitochondria. Elife9:e58041. doi:10.7554/eLife.58041.sa2
88.
NowinskiSMVan VrankenJGDoveKKRutterJ.2018. Impact of mitochondrial fatty acid synthesis on mitochondrial biogenesis. Curr Biol28(20):R1212–9. doi:10.1016/j.cub.2018.08.022
89.
O’BrienRJWongPC. 2011. Amyloid precursor protein processing and Alzheimer’s disease. Annu Rev Neurosci34:185–204. doi:10.1146/annurev-neuro-061010-113613
90.
OkamotoKBrinkerAPaschenSAMoarefiIHayer-HartlMNeupertW, and others. 2002. The protein import motor of mitochondria: a targeted molecular ratchet driving unfolding and translocation. EMBO J21(14):3659–71. doi:10.1093/emboj/cdf358
91.
OnishiMYamanoKSatoMMatsudaNOkamotoK.2021. Molecular mechanisms and physiological functions of mitophagy. EMBO J40(3):e104705. doi:10.15252/embj.2020104705
92.
OrdureauAKrausFZhangJAnHParkSAhfeldtT, and others. 2021. Temporal proteomics during neurogenesis reveals large-scale proteome and organelle remodeling via selective autophagy. Mol Cell81(24):5082–98.e11. doi:10.1016/j.molcel.2021.10.001
93.
OsellameLDBlackerTSDuchenMR. 2012. Cellular and molecular mechanisms of mitochondrial function. Best Pract Res Clin Endocrinol Metab26(6):711–23. doi:10.1016/j.beem.2012.05.003
94.
OteraHIshiharaNMiharaK.2013. New insights into the function and regulation of mitochondrial fission. Biochim Biophys Acta1833(5):1256–68. doi:10.1016/j.bbamcr.2013.02.002
95.
PadmanBSNguyenTNUoselisLSkulsuppaisarnMNguyenLKLazarouM.2019. LC3/GABARAPs drive ubiquitin-independent recruitment of Optineurin and NDP52 to amplify mitophagy. Nat Commun10(1):408. doi:10.1038/s41467-019-08335-6
96.
PanelMGhalehBMorinD.2018. Mitochondria and aging: a role for the mitochondrial transition pore?Aging Cell17(4):e12793. doi:10.1111/acel.12793.
97.
PatergnaniSSuskiJMAgnolettoCBononiABonoraMDe MarchiE, and others. 2011. Calcium signaling around mitochondria associated membranes (MAMs). Cell Commun Signal9:19. doi:10.1186/1478-811X-9-19
98.
PaumardPVaillierJCoularyBSchaefferJSoubannierVMuellerDM, and others. 2002. The ATP synthase is involved in generating mitochondrial cristae morphology. EMBO J21(3):221–30. doi:10.1093/emboj/21.3.221.
99.
PerkinsGATjongJBrownJMPoquizPHScottRTKolsonDR, and others. 2010. The micro-architecture of mitochondria at active zones: electron tomography reveals novel anchoring scaffolds and cristae structured for high-rate metabolism. J Neurosci30(3):1015–26. doi:10.1523/JNEUROSCI.1517-09.2010
100.
PickrellAMYouleRJ. 2015. The roles of PINK1, PARKIN, and mitochondrial fidelity in Parkinson’s disease. Neuron85(2):257–73. doi:10.1016/j.neuron.2014.12.007
101.
PradeepkiranJAHindleAKshirsagarSReddyPH. 2022. Are mitophagy enhancers therapeutic targets for Alzheimer’s disease?Biomed Pharmacother149:112918. doi:10.1016/j.biopha.2022.112918
102.
PradeepkiranJAMunikumarMReddyAPReddyPH. 2021. Protective effects of a small molecule inhibitor ligand against hyperphosphorylated tau-induced mitochondrial and synaptic toxicities in Alzheimer’s disease. Hum Mol Genet31(2):244–261. doi:10.1093/hmg/ddab244
103.
PradeepkiranJAReddyPH. 2019. Structure based design and molecular docking studies for phosphorylated tau inhibitors in Alzheimer’s disease. Cells8(3):260. doi:10.3390/cells8030260
104.
PradeepkiranJAReddyPH. 2020. Defective mitophagy in Alzheimer’s disease. Ageing Res Rev64:101191. doi:10.1016/j.arr.2020.101191
105.
PrasuhnJDavisRLKumarKR. 2021. Targeting mitochondrial impairment in Parkinson’s disease: challenges and opportunities. Front Cell Dev Biol8:615461. doi:10.3389/fcell.2020.615461
QuinnPMJMoreiraPIAmbrósioAFAlvesCH. 2020. PINK1/PARKIN signaling in neurodegeneration and neuroinflammation. Acta Neuropathol Commun8(1):189. doi:10.1186/s40478-020-01062-w
108.
QuirósPMLangerTLópez-OtínC.2015. New roles for mitochondrial proteases in health, ageing and disease. Nat Rev Mol Cell Biol16(6):345–59. doi:10.1038/nrm3984
109.
RajmohanRReddyPH. 2017. Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer’s disease neurons. J Alzheimers Dis57(4):975–99. doi:10.3233/JAD-160612
110.
RaoSGhaniMGuoZDemingYWangKSimsR, and others. 2018. An APOE-independent cis-eSNP on chromosome 19q13.32 influences tau levels and late-onset Alzheimer’s disease risk. Neurobiol Aging66(178). doi:10.1016/j.neurobiolaging.2017.12.027
111.
RatherMAKhanAAlshahraniSRashidHQadriMRashidS, and others. 2021. Inflammation and Alzheimer’s disease: mechanisms and therapeutic implications by natural products. Mediators Inflamm2021:9982954. doi:10.1155/2021/9982954
112.
ReddyPH. 2009. Role of mitochondria in neurodegenerative diseases: mitochondria as a therapeutic target in Alzheimer’s disease. CNS Spectr8Suppl 7:8–13. doi:10.1017/s1092852900024901
113.
ReddyPH. 2013. Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer’s disease?Biochim Biophys Acta1832(1):67–75. doi:10.1016/j.bbadis.2012.09.003
114.
ReddyPHOliverDM. 2019. Amyloid beta and phosphorylated tau-induced defective autophagy and mitophagy in Alzheimer’s disease. Cells8(5):488. doi:10.3390/cells8050488
115.
ReddyPHReddyTPManczakMCalkinsMJShirendebUMaoP.2011. Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases. Brain Res Rev67(1–2):103–18. doi:10.1016/j.brainresrev.2010.11.004
116.
ReddyPHTripathiRTroungQTirumalaKReddyTPAnekondaV, and others. 2012. Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer’s disease: implications to mitochondria-targeted antioxidant therapeutics. Biochim Biophys Acta1822(5):639–49. doi:10.1016/j.bbadis.2011.10.011
117.
RenLChenXChenXLiJChengBXiaJ.2020. Mitochondrial dynamics: fission and fusion in fate determination of mesenchymal stem cells. Front Cell Dev Biol8:580070. doi:10.3389/fcell.2020.580070
118.
RogovVVSuzukiHMarinkovićMLangVKatoRKawasakiM, and others. 2017. Phosphorylation of the mitochondrial autophagy receptor Nix enhances its interaction with LC3 proteins. Sci Rep7(1):1131. doi:10.1038/s41598-017-01258-6
119.
RoyMReddyPHIijimaMSesakiH.2015. Mitochondrial division and fusion in metabolism. Curr Opin Cell Biol33:111–8. doi:10.1016/j.ceb.2015.02.001
120.
SafiehMKorczynADMichaelsonDM. 2019. ApoE4: an emerging therapeutic target for Alzheimer’s disease. BMC Med17(1). doi:10.1186/s12916-019-1299-4
121.
SchenkelLCBakovicM.2014. Formation and regulation of mitochondrial membranes. Int J Cell Biol2014:709828. doi:10.1155/2014/709828
122.
ScottIYouleRJ. 2010. Mitochondrial fission and fusion. Essays Biochem47:85–98. doi:10.1042/bse0470085
123.
SekineSYouleRJ. 2018. PINK1 import regulation; a fine system to convey mitochondrial stress to the cytosol. BMC Biol16(1):2. doi:10.1186/s12915-017-0470-7
124.
SheladiaSReddyPH. 2021. Age-related chronic diseases and Alzheimer’s disease in Texas: a hispanic focused study. J Alzheimers Dis Rep5(1). doi:10.3233/ADR-200277
125.
ShenLJiaJ.2016. An overview of genome-wide association studies in Alzheimer’s disease. Neurosci Bull32(2). doi:10.1007/s12264-016-0011-3
126.
ShengZHCaiQ.2012. Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration. Nat Rev Neurosci13(2):77–93. doi:10.1038/nrn3156
127.
Shiba-FukushimaKInoshitaTHattoriNImaiY.2014. Lysine 63–linked polyubiquitination is dispensable for PARKIN-mediated mitophagy. J Biol Chem289(48):33131–6. doi:10.1074/jbc.C114.580944
128.
Shoshan-BarmatzVNahon-CrystalEShteinfer-KuzmineAGuptaR.2018. VDAC1, mitochondrial dysfunction, and Alzheimer’s disease. Pharmacol Res131:87–101. doi:10.1016/j.phrs.2018.03.010
129.
SimCHLioDSMokSSMastersCLHillAFCulvenorJG, and others. 2006. C-terminal truncation and Parkinson’s disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1. Hum Mol Genet15(21):3251–62. doi:10.1093/hmg/ddl398
130.
SinghAFaccendaDCampanellaM.2021. Pharmacological advances in mitochondrial therapy. EBioMedicine65:103244. doi:10.1016/j.ebiom.2021.103244
131.
SmilanskyADangoorLNakdimonIBen-HailDMizrachiDShoshan-BarmatzV.2015. The voltage-dependent anion channel 1 mediates amyloid β toxicity and represents a potential target for Alzheimer’s disease therapy. J Biol Chem290(52):30670–83. doi:10.1074/jbc.M115.691493
132.
SongMZhaoXSongF.2021. Aging-dependent mitophagy dysfunction in Alzheimer’s disease. Mol Neurobiol58(5):2362–78. doi:10.1007/s12035-020-02248-y
133.
SongZGhochaniMMcCafferyJMFreyTGChanDC. 2009. Mitofusins and OPA1 mediate sequential steps in mitochondrial membrane fusion. Mol Biol Cell20(15):3525–32. doi:10.1091/mbc.e09-03-0252
134.
TammineniPJeongYYFengTAikalDCaiQ.2017. Impaired axonal retrograde trafficking of the retromer complex augments lysosomal deficits in Alzheimer’s disease neurons. Hum Mol Genet26(22):4352–66. doi:10.1093/hmg/ddx321.
135.
TilokaniLNagashimaSPaupeVPrudentJ.2018. Mitochondrial dynamics: overview of molecular mechanisms. Essays Biochem62(3):341–60. doi:10.1042/EBC20170104
136.
TodorovaVBloklandA.2017. Mitochondria and synaptic plasticity in the mature and aging nervous system. Curr Neuropharmacol15(1):166–73. doi:10.2174/1570159x14666160414111821
137.
ToressonHGrantSG. 2005. Dynamic distribution of endoplasmic reticulum in hippocampal neuron dendritic spines. Eur J Neurosci22(7):1793–8. doi:10.1111/j.1460-9568.2005.04342.x
138.
TwigGHydeBShirihaiOS. 2008. Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim Biophys Acta1777(9):1092–7. doi:10.1016/j.bbabio.2008.05.001
139.
UrbaniAProsdocimiECarrerAChecchettoVSzabòI.2021. Mitochondrial ion channels of the inner membrane and their regulation in cell death signaling. Front Cell Dev Biol8:620081. doi:10.3389/fcell.2020.620081
140.
van der FlierWMScheltensP.2005. Epidemiology and risk factors of dementia. J Neurol Neurosurg Psychiatry76Suppl 5:v2–7. doi:10.1136/jnnp.2005.082867
141.
VijayanMAlvirRVAlvirRVBunquinLEPradeepkiranJAReddyPH. 2022. A partial reduction of VDAC1 enhances mitophagy, autophagy, synaptic activities in a transgenic tau mouse model. Aging Cell21(8):e13663. doi:10.1111/acel.13663
142.
ViscomiCSorianoME. 2022. Molecular research on mitochondrial dysfunction. Int J Mol Sci23(12):6845. doi:10.3390/ijms23126845
WangYLiuNLuB.2019a. Mechanisms and roles of mitophagy in neurodegenerative diseases. CNS Neurosci Ther25(7):859–75. doi:10.1111/cns.13140
145.
WangYXuEMusichPRLinF.2019b. Mitochondrial dysfunction in neurodegenerative diseases and the potential countermeasure. CNS Neurosci Ther25(7):816–824. doi:10.1111/cns.13116
146.
WestrateLMDroccoJAMartinKRHlavacekWSMacKeiganJP. 2014. Mitochondrial morphological features are associated with fission and fusion events. PLoS One. 9(4):e95265. doi:10.1371/journal.pone.0095265
147.
WhiteDNStowellMHB. 2021. Room for two: the synaptophysin/synaptobrevin complex. Front Synaptic Neurosci13:740318. doi:10.3389/fnsyn.2021.740318
148.
WongEDWagnerJAScottSVOkreglakVHolewinskeTJCassidy-StoneA, and others. 2003. The intramitochondrial dynamin-related GTPase, Mgm1p, is a component of a protein complex that mediates mitochondrial fusion. J Cell Biol160(3):303–11. doi:10.1083/jcb.200209015
149.
XiuSLiaoQSunLChanP.2019. Risk factors for cognitive impairment in older people with diabetes: a community-based study. Ther Adv Endocrinol Metab10:2042018819836640. doi:10.1177/2042018819836640
150.
YangMLiCYangSXiaoYXiongXChenW, and others. 2020. Mitochondria-associated ER membranes—the origin site of autophagy. Front Cell Dev Biol8:595. doi:10.3389/fcell.2020.00595
151.
YapaNMBLisnyakVReljicBRyanMT. 2021. Mitochondrial dynamics in health and disease. FEBS Lett595(8):1184–204. doi:10.1002/1873-3468.14077
152.
YooKSLeeKOhJYLeeHParkHParkYS, and others. 2019. Postsynaptic density protein 95 (PSD-95) is transported by KIF5 to dendritic regions. Mol Brain12(1):97. doi:10.1186/s13041-019-0520-x
YouleRJvan der BliekAM. 2012. Mitochondrial fission, fusion, and stress. Science337(6098):1062–5. doi:10.1126/science.121985
155.
ZekonyteJSakaiKNicollJAWellerROCarareRO.2016. Carare, quantification of molecular interactions between ApoE, amyloid-beta (Aβ) and laminin: relevance to accumulation of Aβ in Alzheimer’s disease. Biochim Biophys Acta1862(5). doi:10.1016/j.bbadis.2015.08.025
ZhangJ. 2013. Autophagy and mitophagy in cellular damage control. Redox Biol1(1):19–23. doi:10.1016/j.redox.2012.11.008
158.
ZhangJNeyPA. 2009. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ16(7):939–46. doi:10.1038/cdd.2009.16
159.
ZhangJNeyPA. 2011. Mechanisms and biology of B-cell leukemia/lymphoma 2/adenovirus E1B interacting protein 3 and Nip-like protein X. Antioxid Redox Signal 15;14(10):1959–69. doi:10.1089/ars.2010.3772
160.
ZhengWXieWYinDLuoRLiuMGuoF.2019. ATG5 and ATG7 induced autophagy interplays with UPR via PERK signaling. Cell Commun Signal17(1):42. doi:10.1186/s12964-019-0353-3
161.
ZorovDBJuhaszovaMSollottSJ. 2014. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev94(3):909–50.
162.
ZorzanoALiesaMSebastiánDSegalésJPalacínM.2010. Mitochondrial fusion proteins: dual regulators of morphology and metabolism. Semin Cell Dev Biol21(6):566–74. doi:10.1016/j.semcdb.2010.01.002
